Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    23986162 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis
Conditions: Psoriasis-Type Psoriasis;   Plaque-Type Psoriasis
Intervention: Drug: Apremilast

Study has passed its completion date and status has not been verified in more than two years.